Impact of genomic aberrations including chromosome 1 abnormalities on the outcome of patients with relapsed or refractory multiple myeloma treated with lenalidomide and dexamethasone (Q42867447)
Jump to navigation
Jump to search
scientific article published on October 7, 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Impact of genomic aberrations including chromosome 1 abnormalities on the outcome of patients with relapsed or refractory multiple myeloma treated with lenalidomide and dexamethasone |
scientific article published on October 7, 2010 |
Statements
1 reference
Impact of genomic aberrations including chromosome 1 abnormalities on the outcome of patients with relapsed or refractory multiple myeloma treated with lenalidomide and dexamethasone (English)
1 reference
Hong Chang
1 reference
Allan Jiang
1 reference
Connie Qi
1 reference
Young Trieu
1 reference
Christine Chen
1 reference
Donna Reece
1 reference
7 October 2010
1 reference
1 reference
51
1 reference
11
1 reference
2084-2091
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference